Ian Ingram The FDA on Wednesday approved a new all-oral regimen for newly diagnosed acute myeloid leukemia (AML) in patients ineligible for intensive chemotherapy.
Ian Ingram is a Deputy Managing Editor at MedPage Today. He covers a range of topics within medicine and healthcare, focusing on consumer health, drugs and medication, public health, and the healthcare system, with a particular interest in alternative medicine. Ian's work has been featured in Knowledia, ExBulletin, MedPage Today, and MSN.











